(
out of
262
reviews
)
Schedule an Appointment with U of U Health (MyChart)
If you're an existing patient of this provider, please use your U of U Health (MyChart) account to schedule your appointment.
Sign in to U of U Health (MyChart)Haven't set up a U of U Health (MyChart) account yet? Create an account
Need Assistance?
If you're having trouble signing in, need guidance on using U of U Health (MyChart), or require support with your account, please visit our FAQ page.
Clinical Locations
Primary Location
Sugar House Health Center
1280 E. Stringham Avenue
Salt Lake City
,
UT
84106
Board Certification
|
American Board of Internal Medicine (Internal Medicine)
American Board of Internal Medicine (Sub: Hematology)
Educational Commission for Foreign Medical Graduates
National Certification Board for Anticoagulation Providers
|
Patient Rating
Patients consistently describe Dr. Lim and her team as kind, caring, and deeply attentive. Reviewers highlight clear, thorough explanations, patience in answering questions, and feeling listened to and included in treatment decisions. Many also note the staff's supportive approach and responsiveness after visits, and express strong trust in her clinical expertise.
Generated via Patient Reviews
4.9
/5
( out of
262 reviews
)
The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers. The scale on which responses are measured is 1 to 5 with 5 being the best score.
Patient comments are gathered from our patient experience survey and displayed in their entirety. For the convenience of our visitors, some patient comments have been translated from their original language into English while preserving their original meaning as accurately as possible. Patients are de-identified for confidentiality and patient privacy.
Board Certification and Academic Information
| Academic Departments |
Internal Medicine
-Professor (Clinical) |
|---|---|
| Academic Divisions |
Hematology & Hematologic Malignancies
|
| Board Certification |
American Board of Internal Medicine (Internal Medicine)
American Board of Internal Medicine (Sub: Hematology)
Educational Commission for Foreign Medical Graduates
National Certification Board for Anticoagulation Providers
|
Education history
| Graduate Training | Clinical Research - Medical University of South Carolina | M.S. |
|---|---|---|
| Fellowship | Hematology/Oncology - University of North Carolina at Chapel Hill School of Medicine | Fellow |
| Residency | Internal Medicine - Mayo School of Graduate Medical Education | Resident |
| Diploma | Palliative Medicine - Cardiff University School of Medicine | Diploma |
| Professional Medical | Clinical Medicine - Cambridge University School of Clinical Medicine | MB BChir |
| Graduate Training | Medical Sciences - Magdalene College, University of Cambridge | M.A. |
Selected Publications
Journal Article
- York G, Taylor S, Lim MY (2026). Underrecognized Iron Deficiency in Pregnant Women With Inherited Bleeding Disorders. Haemophilia.
- Powers JM, Lim MY, Achebe MO, Akpan IJ, Auerbach M, Brown MC, Cardenas MP, Cromwell C, DeLoughery TG, Fleming RE, Fraga M, Goshua G, James PD, Lewkowitz AK, May JE, Nnadozie G, Ogunnaya F, Ruiz-Arguelles GJ, Sholzberg M, Van Doren L, Weyand AC, Zeller MP, Azzam M, Choaib A, Hamarsha Q, Kawtharany H, Khawandi J, Mustafa RA (2026). American Society of Hematology 2026 guidelines for diagnosis of iron deficiency. Blood Adv.
- Abou-Ismail MY, Sridharan M, Kalvehalli Kashinath S, Singal M, Singh R, Khouri A, Bechara SB, Peterson C, Rao AV, Lee HJ, Mitchell C, Kandula M, Zhang C, Kouides PA, Nayak L, Mazepa M, Lim MY (2026). Mortality Prediction in Immune TTP Remains Challenging Despite AI Advances. Blood Adv.
- Lim MY, Ito S, Goshua G, Chaiyakunapruk N, Yoo M, Nelson R (2026). Cost-effectiveness analysis of emicizumab use in hospitalized older individuals with acquired hemophilia A. Blood Vessel Thromb Hemost, 3(4), 100195.
- Bakow BR, Zon RL, Agarwal S, Akpan IJ, Lim MY, Parks AL, Pfeffer MA, Rajpurkar M, Rosovsky RP, Samuelson Bannow B, Yang X, Baumann Kreuziger L (2026). Prevalence of iron deficiency in reproductive-age females on anticoagulation. Thromb Res, 264, 109792.
- Lemieux ME, Lim MY (2026). Thrombocytopenia in Pregnancy: A 5-Year Analysis of Characteristics and Practices From a Tertiary Academic Center. Int J Lab Hematol.
- Lim MY, Gangaraju R, Jafari O, Yang Z, Tiong JWT, Chiang ECL, Ma S, Jiang JY, Ryu J, Lam BD, Ranjan M, Li A (2026). Clinically Relevant Bleeding in Individuals With Cancer: Insights From a Nationwide Cohort Study. Am J Hematol.
- Dargaud Y, Castaman G, Gualtierotti R, Lim M, Shapiro S, Ardila J, Fijnvandraat K, Hermans C (2026). Thrombin Generation as a Potential Surrogate Marker of Hemostatic Status in the Era of Novel Therapies for Hemophilia. Thromb Haemost.
- Singh R, Khouri A, Lee HJ, Kashinath SK, Singal M, Peterson C, Bechara SB, Rao AV, Mitchell C, Zhang C, Kouides P, Nayak L, Lim MY, Abou-Ismail MY (2026). A multicenter analysis revisiting the PLASMIC score: performance limitations and the impact of age, MCV, and LDH. Blood Vessel Thromb Hemost, 3(2), 100163.
- Godby RC, Cogan J, Cuker A, Garcia D, Lim MY, Masias C, May JE, Morton CT, Schaefer JK, Shah S, Zumberg MS, Marshall AL (2025). Foundations of systems-based hematology: thematic analysis of expert interviews to guide curriculums and promote growth. Blood Adv, 10(6), 2038-2046.
- Batsuli G, Lewandowska MD, Lim MY, Tickle K, Baldwin MK, Bender R, Davila J, Hayes B, Jacobson-Kelly A, Kouides P, Lambert MP, Nataraj S, Sholzberg M, Sinha R, Al-Samkari H, Dunn AL (2026). National Bleeding Disorder Foundation Clinical Practice Recommendations for Laboratory Screening of Iron Deficiency With and Without Anemia in the Inherited Bleeding Disorders Population. Haemophilia.
- Fedewa SA, Buckner TW, Cafuir L, Sidonio RF, Lim M, Kempton CL (2025). Approaches to Identify People With Haemophilia With Medicare Claims Data. Haemophilia, 32(2), 410-417.
- Lim MY, Christensen GB, Rodgers GM, Simonsen SE (2026). Pregnancy outcomes in women with Von Willebrand disease: a statewide cohort study. Res Pract Thromb Haemost, 10(2), 103383.
- Tatake IJ, Singh R, Cromwell C, Bakow B, Cogan J, Gaddh M, Gangaraju R, Lim MY, Morton CT, Peseski AM, Rosovsky RP, Youkhana K, Kreuziger LB (2025). Qualitative comparison of perioperative anticoagulation management guidelines across US institutions. Thromb Res, 257, 109569.
- Llus N, Kunzler F, Tsamalaidze L, Asbun D, Manresa-Rocamora A, Blasco-Peris C, Alseidi A, Chan C, Teh C, Conrad C, Ferrone C, Telem D, Targarona E, Vega EA, Reitano E, Romano F, Dudina G, Al-Samkari H, Khatkov I, Freed JA, Conlon K, Feldman LS, Cappellini MD, Barabanshikova MV, Gimnez M, Nakamura M, Lim MY, Hilal MA, Dimachk M, Alexakis N, DeAngelis N, Bouvy ND, Marco P, Llamas P, Gangaraju R, Mehta RP, Snchez-Cabs S, Ross SB, Perretta S, Taner T, Shen YM, Demetrashvili Z, Llus F, Nagalla S, Asbun HJ (2025). Management of splanchnic venous thrombosis after splenectomy in hematologic diseases. systematic review, meta-analysis and consensus guidelines. Int J Surg.
- Bruno AM, Job KM, Rower JE, Allshouse AA, Zinkhan EK, Lim MY, Shakib JH, Federspiel JJ, Watt KM, Metz TD, Branch DW (2025). Prophylactic-Dose Rivaroxaban Transfer Into Human Milk. Obstet Gynecol, 147(5), e116-e119.
- Lim MY, Cogan JC, Cromwell C, Gaddh M, Gangaraju R, Morton C, Peseski A, Singh R, Tatake I, Youkhana K, Kreuziger LB (2025). Comparative analysis of perioperative management of antiplatelet agent guidelines across US institutions. Thromb Res, 255, 109493.
- Lim MY, Lee K, Johnsen JM, Key NS (2025). F8 Variants and Inhibitor Development in a Multiethnic Cohort of Nonsevere Haemophilia A. Haemophilia, 31(6), 1217-1225.
- Lim MY, Funkhouser KB, Anguiano KC, Johnsen JM, Horowitz GS, Chupka J, Chitlur M (2025). Mild Matters: A Survey of US Haematologists on the Diagnosis and Management of Individuals With Mild Haemophilia. Haemophilia.
- Lim MY, Anguiano KC, Carpenter SL, Funkhouser KB (2025). Building access to care for Women and Girls(+) with Bleeding Disorders: the WGBD Clinic of Excellence Model. Res Pract Thromb Haemost, 9(7), 103203.
- Parks AL, Jenkins SL, Vazquez SR, Swenson E, Lim MY, Moser KA, Witt DM (2025). The clot cases conference: a proposed model to enhance multidisciplinary thrombosis care. J Thromb Thrombolysis, 59(1), 161-166.
- Lim MY, Sivaloganathan V, Rodgers GM, Simonsen SE (2025). Development and validation of an algorithm to better identify pregnant women with inherited bleeding disorders within electronic health records. Thromb Res, 246, 109253.
- Fatola A, Evans MD, Brown J, Davis E, Johnson A, Antun AG, Farland AM, Woods R, Metjian A, Park YA, de Ridder G, Gibson B, Kasthuri RS, Liles DK, Eubanks S, Akwaa F, Clover T, Kreuziger LB, Sadler JE, Sridharan M, Go RS, McCrae KR, Upreti HV, Lim MY, Kocher NK, Gangaraju R, Zheng XL, Raval JS, Masias C, Cataland SR, Mazepa M, Chaturvedi S (2024). Relapse-free survival is progressively shortened in a subset of Black patients with immune-mediated TTP treated in the rituximab era. Blood Adv, 9(2), 417-424.
- Streiff MB, Holmstrom B, Angelini D, Ashrani A, Buckner T, Diep R, Fertrin KY, Fogerty AE, Crestani NG, Gangaraju R, Rojas-Hernandez C, Goldhaber SZ, Ibrahim I, Kubal T, Leavitt AD, Lim M, Mann J, Mantha S, Morton C, Nester A, OBrien A, Ortel TL, Pine A, Pishko A, Ranade M, Salmasi A, Schaefer J, Williams E, Wool G, Wun T, Montgomery S, Nguyen J, Freedman-Cass D, Sliker B (2024). Cancer-Associated Venous Thromboembolic Disease, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw, 22(7), 483-506.
- Moshirfar M, Reynolds JC, Moin KA, Lim MY, Stoakes IM, Hoopes PC (2024). Perioperative Recommendations for Corneal Refractive Surgery Patients With Inherited Bleeding Disorders. Cornea, 43(12), 1599-1607.
- Lim MY, Abou-Ismail MY (2024). Double-heterozygous FVL/PTGM: double the trouble. Blood, 143(23), 2347-2349.
- Abou-Ismail MY, Zhang C, Presson AP, Chaturvedi S, Antun AG, Farland AM, Woods R, Metjian A, Park YA, de Ridder G, Gibson B, Kasthuri RS, Liles DK, Akwaa F, Clover T, Kreuziger LB, Sridharan M, Go RS, McCrae KR, Upreti HV, Gangaraju R, Kocher NK, Zheng XL, Raval JS, Masias C, Cataland SR, Johnson AD, Davis E, Evans MD, Mazepa M, Lim MY (2024). A machine learning approach to predict mortality due to immune-mediated thrombotic thrombocytopenic purpura. Res Pract Thromb Haemost, 8(3), 102388.
- Lim MY, Rodgers GM, Branch DW, Simonsen SE (2024). Targeting a higher plasma VWF level at time of delivery in pregnant individuals with von Willebrand disease: Outcomes at a single-institution cohort study. Haemophilia, 30(2), 470-477.
- Abou-Ismail MY, Zhang C, Presson AP, Chaturvedi S, Antun AG, Farland AM, Woods R, Metjian A, Park YA, de Ridder G, Gibson B, Kasthuri RS, Liles DK, Akwaa F, Clover T, Baumann Kreuziger L, Sridharan M, Go RS, McCrae KR, Upreti HV, Gangaraju R, Kocher NK, Zheng XL, Raval JS, Masias C, Cataland SR, Johnson AD, Davis E, Evans MD, Mazepa M, Lim MY (2023). A descriptive analysis of fatal outcomes in immune thrombotic thrombocytopenic purpura in the USTMA TTP Registry. Blood Adv, 8(3), 620-623.
- Ragni MV, Callis J, Daoud N, Hu B, Manuel M, Santos J, Schwartz J, Friedman KD, Kouides P, Kuriakose P, Leavitt AD, Lim MY, Machin N, Recht M, Chrisentery-Singleton T (2023). Observational cohort study of long-term outcomes of liver transplantation in haemophilia. Haemophilia, 30(1), 87-97.
- Wheeler AP, Lim MY, Huguelet PS, Jaffray J, Staber JM, Funkhouser K, Carpenter SL, Weyand AC (2023). Trends in dedicated care for females with bleeding disorders within U.S. hemophilia treatment centers. Am J Hematol, 98(12), E399-E402.
- Cogan JC, McFarland MM, May JE, Lim MY (2023). Quality improvement approaches to heparin-induced thrombocytopenia: a scoping review. Res Pract Thromb Haemost, 7(7), 102219.
- Young A, Lim MY, Sanders J, Branch DW, Simonsen SE (2022). Pregnancy and Childbirth in Women with Bleeding Disorders: A Retrospective Cohort Study. Haemophilia, 29(1), 240-247.
- Montgomery HD, Agarwal AM, Lim MY (2022). A case of azathioprine-induced aplastic anemia. Int J Lab Hematol, 44(6), 1015-1016.
- Bruno AM, Allshouse AA, Campbell HM, Branch DW, Lim MY, Silver RM, Metz TD (2022). Weight-Based Compared with Fixed-Dose Enoxaparin Prophylaxis After Cesarean Delivery: A Randomized Controlled Trial. Obstet Gynecol, 140(4), 575-583.
- Chaturvedi S, Antun AG, Farland AM, Woods R, Metjian A, Park YA, de Ridder G, Gibson B, Kasthuri RS, Liles DK, Akwaa F, Clover T, Baumann Kreuziger L, Sadler JE, Sridharan M, Go RS, McCrae KR, Upreti HV, Liu A, Lim MY, Gangaraju R, Zheng XL, Raval JS, Masias C, Cataland SR, Johnson A, Davis E, Evans MD, Mazepa MA, United States Thrombotic Microangiopathies Consortium (2022). Race, Rituximab, and Relapse in TTP. Blood, 140(12), 1335-1344.
- Simpson SJ, Lim MY, George TI, Rets A (2021). 36-year-old male with X-linked congenital sideroblastic anemia presenting as chronic microcytic anemia with iron overload. Int J Lab Hematol, 44(1), 69-71.
Review
- Lim MY, Ardila J, Castaman G, Dargaud Y, Fijnvandraat K, Gualtierotti R, Hermans C, Shapiro S (2026). Diagnosis and management of hemophilia A and B. [Review]. J Thromb Haemost, 24(7), 2341-2354.
- Lewandowska M, Lim MY (2025). The aging hemophilia patient. [Review]. Hematology Am Soc Hematol Educ Program, 2025(1), 674-681.
- Cogan JC, Burnett AE, Power-Hays A, Barnes GD, Lim MY (2025). Identifying and addressing underuse in hematologic care through systems-based hematology. [Review]. Res Pract Thromb Haemost, 9(4), 102881.
- La Mura V, Colombo M, Foster GR, Angeli P, Miesbach W, Klamroth R, Pierce GF, OMahony B, Lim MY, Hernandez-Gea V, Makris M, Peyvandi F (2024). The management of liver disease in people with congenital bleeding disorders: guidance from European Association for Haemophilia and Allied Disorders, European Haemophilia Consortium, ISTH, and World Federation of Hemophilia. [Review]. J Thromb Haemost, 22(12), 3629-3639.
- Branch DW, Lim MY (2023). How I Diagnose And Treat Antiphospholipid Syndrome In Pregnancy. [Review]. Blood, 143(9), 757-768.
- Lim MY, Abou-Ismail MY, Branch DW (2022). Differentiating and Managing Rare Thrombotic Microangiopathies During Pregnancy and Postpartum. [Review]. Obstet Gynecol, 141(1), 85-108.
- Elshoury A, Schaefer JK, Lim MY, Skalla DP, Streiff MB (2022). Update on Guidelines for the Prevention of Cancer-Associated Thrombosis. [Review]. J Natl Compr Canc Netw, 1-8.
- Thomas VM, Abou-Ismail MY, Lim MY (2021). Off-label Use of Emicizumab in Persons with Acquired Haemophilia A and von Willebrand Disease: A Scoping Review of the Literature. [Review]. Haemophilia, 28(1), 4-17.
- Baljevic M, Sborov DW, Lim MY, Hillengass J, Martin T, Castillo JJ, Streiff MB, Kumar SK, Callander NS (2021). Optimizing Thromboembolism Prophylaxis for the Contemporary Age of Multiple Myeloma. [Review]. J Natl Compr Canc Netw, 20(1), 91-95.
- Lim MY (2021). How Do We Optimally Utilize Factor Concentrates in Persons with Hemophilia? [Review]. Hematology Am Soc Hematol Educ Program, 2021(1), 206-214.
Case Report
- Gleichgerrcht E, Lim MY, Turan TN (2017). Cerebral Venous Sinus Thrombosis Due to Low-molecular-weight Heparin-induced Thrombocytopenia. Neurologist, 22(6), 241-244.
Dr Lim is always amazing!
Dr. Lim is a pro!!!
Dr Lim has a deep background and draws on that to find solutions for the wide variety of patients in her care. I really appreciate it!
Enjoyed my yearly appointment. She answered all my questions, helped me set a plan for the next year to continue good health. Maked sure that if I need anything to reach out. I know I am I. Good hands
She is so thorough and caring. No matter what your issue is, she wants to help you! Highly recommend!
She cares very much about each of her patients
Dr Lim was great. Genuinely cared about me and my visit. Very helpful in fully explaining my condition and listening to my concerns. Responded to my questions after my visit very quickly and answered everything I asked for. I would definitely recommend Dr. Lim to anybody who needs a hematologist.
Dr Lim was extremely knowledgeable and helpful. She was patient to answer all my questions and educate me on different options. She was wonderful to work with!
A person with extensive medical experience in his field, attentive and excellent in his care. [TRANSLATED]
Very kind and caring
The score of very good in your survey does not do justice to Dr. Lim. She deserves above a beyond and above category. She was very welcoming. I felt listened to and very much included in the treatment plan.
She is an excellent physician.
Dr. Lim is wonderful! She is thorough, kind, and concerned about my health. I appreciate all she has done to help me understand my condition and reassure me.
Dr Lim has has knowledge about her patients, AND willingly shares her knowledge readily. Complex "issues" are explained in layman's terms and there are no questions that are not answered. Dr. Lim takes the time for questions and I have never felt rushed. Any time a facility, such as University of Utah, makes me feel as though I am the only person in the world that they are helping...I can't help but thinks this is the best "place" to be!
I fully trust Dr Lim's treatment.
Was very carrying and kind. Answered all my questions and help me understand my health and I know I am in good hands.
Very knowledgeable very kind I am SO THANKFUL for Dr Lim
Dr. LIM is a great doctor. She is very supportive and caring.
Dr Lim is extremely helpful and efficient, I wished I had found her a long time ago, she has given me a high quality of life.
Superior Hematologist So kind and patient and took the time to talk to me.
Dr. Lim is an all-star physician.
Dr Lim and Staff Kealan & Carmen,are beyond those who merely come to work and simply do their job. Dr Kim, is genuinely interested. supporting staff actually cares. I was able to "heal" quicker, faster & sooner, because I had people who supported me physically and mentally!
Dr Lim is fantastic... She listens and addresses my concerns even when I ask the same thing over and over. Until she is sure that I understand
I trust Dr. Lim wholeheartedly with my care. She counsels with me and makes me aware of the options available and the pros and cons of each one. She was very thorough in discussing my experience with me to ensure she understood where I was coming from. She is extremely knowledgeable, kind, and easy to talk to. Made sure I had the chance to discuss all my questions.